181 related articles for article (PubMed ID: 16137213)
61. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective.
Laliberté F; Bookhart BK; Vekeman F; Corral M; Duh MS; Bailey RA; Piech CT; Lefebvre P
J Manag Care Pharm; 2009 May; 15(4):312-22. PubMed ID: 19422271
[TBL] [Abstract][Full Text] [Related]
62. HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.
Wysham CH; Pilon D; Ingham M; Lafeuille MH; Emond B; Kamstra R; Pfeifer M; Lefebvre P
Endocr Pract; 2018 Mar; 24(3):273-287. PubMed ID: 29547044
[TBL] [Abstract][Full Text] [Related]
63. Medication Regimen Complexity and A1C Goal Attainment in Underserved Adults With Type 2 Diabetes.
Yeh A; Shah-Manek B; Lor KB
Ann Pharmacother; 2017 Feb; 51(2):111-117. PubMed ID: 28042735
[TBL] [Abstract][Full Text] [Related]
64. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
Khandker RK; Kruzikas DT; McLaughlin TP
J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
[TBL] [Abstract][Full Text] [Related]
65. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
[TBL] [Abstract][Full Text] [Related]
66. Historical cohort analysis of treatment patterns for patients with type 2 diabetes initiating metformin monotherapy.
Hazel-Fernandez L; Xu Y; Moretz C; Meah Y; Baltz J; Lian J; Kimball E; Bouchard J
Curr Med Res Opin; 2015; 31(9):1703-16. PubMed ID: 26154837
[TBL] [Abstract][Full Text] [Related]
67. Quality measure attainment in patients with type 2 diabetes mellitus.
Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Sheng Duh M; Lefebvre P
Am J Manag Care; 2014 Jan; 20(1 Suppl):s5-15. PubMed ID: 24512194
[TBL] [Abstract][Full Text] [Related]
68. Analysis of cost and utilization of health care services before and after initiation of insulin therapy in patients with type 2 diabetes mellitus.
Rosenblum MS; Kane MP
J Manag Care Pharm; 2003; 9(4):309-16. PubMed ID: 14613449
[TBL] [Abstract][Full Text] [Related]
69. Impact of adherence and weight loss on glycemic control in patients with type 2 diabetes: cohort analyses of integrated medical record, pharmacy claims, and patient-reported data.
McAdam-Marx C; Bellows BK; Unni S; Wygant G; Mukherjee J; Ye X; Brixner DI
J Manag Care Spec Pharm; 2014 Jul; 20(7):691-700. PubMed ID: 24967522
[TBL] [Abstract][Full Text] [Related]
70. The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
Smolen HJ; Murphy DR; Gahn JC; Yu X; Curtis BH
J Manag Care Spec Pharm; 2014 Sep; 20(9):968-84. PubMed ID: 25166296
[TBL] [Abstract][Full Text] [Related]
71. Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.
Pelletier EM; Smith PJ; Boye KS; Misurski DA; Tunis SL; Minshall ME
Appl Health Econ Health Policy; 2008; 6(2-3):103-12. PubMed ID: 19231904
[TBL] [Abstract][Full Text] [Related]
72. A prospective study of glycemic control during holiday time in type 2 diabetic patients.
Chen HS; Jap TS; Chen RL; Lin HD
Diabetes Care; 2004 Feb; 27(2):326-30. PubMed ID: 14747208
[TBL] [Abstract][Full Text] [Related]
73. Increased A1C among adult emergency department patients with type 2 diabetes.
Silverman RA; Arora H; Kwiatkowski TM; Graff KK; Baneman E; Kohn N; Foss Bowman C; Smith KN; Lesser ML
Ann Emerg Med; 2011 Jun; 57(6):575-81. PubMed ID: 21227541
[TBL] [Abstract][Full Text] [Related]
74. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
[TBL] [Abstract][Full Text] [Related]
75. Diabetes management in the real world and the impact of adherence to guideline recommendations.
Lian J; Liang Y
Curr Med Res Opin; 2014 Nov; 30(11):2233-40. PubMed ID: 25105305
[TBL] [Abstract][Full Text] [Related]
76. Predictors and Clinical Outcomes of Treatment Intensification in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin in a Real-World Setting.
Kallenbach L; Shui AM; Cheng WY; Fan T; Hu W; Zichlin ML; Duh MS; Ye F; Levin PA
Endocr Pract; 2018 Sep; 24(9):805-814. PubMed ID: 29975575
[TBL] [Abstract][Full Text] [Related]
77. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
78. Statewide data infrastructure supports population health management: diabetes case study.
Jones C; Mohlman MK; Jorgenson D; Finison K; McGee K; Kastensmith H
Am J Manag Care; 2017 Oct; 23(10):e331-e339. PubMed ID: 29087637
[TBL] [Abstract][Full Text] [Related]
79. Incremental cardiovascular costs and resource use associated with diabetes: an assessment of 29,863 patients in the US managed-care setting.
Straka RJ; Liu LZ; Girase PS; DeLorenzo A; Chapman RH
Cardiovasc Diabetol; 2009 Sep; 8():53. PubMed ID: 19781099
[TBL] [Abstract][Full Text] [Related]
80. Glycemic Control Outcomes After Canagliflozin Initiation: Observations in a Medicare and Commercial Managed Care Population in Clinical Practice.
Bailey RA; Schwab P; Xu Y; Pasquale M; Renda A
Clin Ther; 2016 Sep; 38(9):2046-2057.e2. PubMed ID: 27567160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
